More news: Software
Agency / Source: SAS Institute, Inc.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

SAS Life Science Analytics Help Contract Research Organization Gunvatta Expedite Clinical Trials and FDA Reporting - Clinical research and drug development accelerated via analytics - Gunvatta.com / SAS.com
SAS Life Science Analytics Help Contract Research Organization Gunvatta Expedite Clinical Trials and FDA Reporting

 

PRZOOM - /newswire/ - Cary, NC, United States, 2022/06/22 - Clinical research and drug development accelerated via analytics - Gunvatta.com / SAS.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Bringing life-changing therapies to market requires pharmaceutical companies to efficiently design and run clinical trials, gather and analyze massive amounts of data, and manage a complicated regulatory review process. SAS, a leader in clinical research analytics, delivers powerful technologies to support the life sciences industry including machine learning, AI and analytics for IoT through the SAS® Life Science Analytics Framework on Azure.

The advanced analytics platform a single, open, cloud-native statistical computing environment for clinical trial analysis and submission helps pharmaceutical companies navigate the heavily regulated world of clinical research analytics and bring new therapies to the world faster.

Delivering the power of analytics in the cloud

From drug discovery to regulatory approval, developing a new medicine can take over a decade with a price tag in the billions. The clinical research required to achieve approval from the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regulatory authorities involves massive amounts of data that can be difficult to manage, share and analyze, creating delays that affect patients’ well-being.

The cloud-based SAS Life Science Analytics Framework on Azure features an integrated and collaborative environment to manage and analyze clinical trial information as well as deliver trial results for the FDA and other global regulatory agencies’ review. With the analytic solution, life sciences organizations can extract valuable insights from clinical data, mitigate risk, increase efficiency, and speed time to market for lifesaving pharmaceuticals.

Helping pharma accelerate clinical research

“The primary goal is to get drugs approved so that they can reach patients,” said Bhawna Goel, CEO of Gunvatta. “The faster you can do that, the greater benefit for the patient and to help save lives.”

Gunvatta USA, Inc. (gunvatta.com), a contract research organization (CRO) headquartered in Washington, DC, helps clients collect, manage, analyze and visualize the terabytes of clinical and healthcare data produced by pharmaceutical and biotechnology companies, hospitals, and provider groups.

With the SAS Life Science Analytics Framework, Gunvatta has modernized the way it approaches clinical trials. The CRO helps life sciences organizations reduce risk with secure data access, ensure data and results are validated, maintain an audit trail, and report their data to health authorities like the FDA.

“The biggest advantage of the SAS Life Science Analytics Framework is that the analytics platform is cloud-based,” said Goel. “I feel like SAS has jumped 15 to 20 steps ahead of where the market is.”

Developing cutting-edge clinical research tools

SAS life science experts will attend the DIA Global Annual Meeting this week in Chicago to share next generation approaches for driving excellence and innovation in clinical trial operations.

At DIA, SAS will preview SAS Clinical Enrollment Simulation Cloud a cloud-native, solution based in SAS® Viya® 4 that enables life sciences and contract research organizations to simulate the outcome of the complex clinical trial enrollment process in a virtual world, resulting in faster, more strategic clinical trial enrollment plans.

The new SaaS offering available later this year on the Microsoft Azure Marketplace uses a powerful discrete event simulation analytical engine to model the clinical trial enrollment process as it evolves over time, facilitating improved insights to guide enrollment strategy and meet contracted patient targets.

“SAS Clinical Enrollment Simulation Cloud is highly differentiated from traditional methodologies for predicting trial enrollment,” said Jim Box, Life Sciences Principal Data Scientist at SAS. “The technology helps life sciences organizations reduce timelines, minimize costs, and gain greater insight to inform clinical enrollment planning and rescue.”
Modernizing clinical trials for the future

While the current clinical development research model can be an obstacle to the creation of safe, cost-effective therapies, the COVID-19 pandemic and other events set the stage for disruption in clinical trials.

“The silver lining of the pandemic for the life sciences industry is the acceleration of digital transformation and modernization of clinical research,” said Simon Tilley, Health and Life Sciences Product Director at SAS. “We experienced widespread adoption of innovative approaches, such as decentralized clinical trials for the development of new vaccines.”

“While the business benefits of modernizing clinical research include significant cost savings, efficiency improvements, accelerated time to regulatory approval and faster time to market, it is patients who stand to gain the most from clinical trial innovation.”

About SAS

SAS (sas.com) is the leader in analytics. Through innovative software and services, SAS empowers and inspires customers around the world to transform data into intelligence. SAS gives you THE POWER TO KNOW®.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: SAS Institute, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
Software Warnings - IMPORTANT:
Always be aware/cautious about what you download on your computer/mobile! PURCHASE SOFTWARE related keywords / Banner Ads. Click HERE for details!
.

 
  Your Banner Ad showing on ALL
Software articles,
CATCH Visitors via Your Competitors Announcements!


SAS Life Science Analytics Help Contract Research Organization Gunvatta Expedite Clinical Trials and FDA Reporting

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
SAS Life Science Analytic | Gunvatta USA, Inc.
Contact: Jennifer James - SAS.com 
919-531-0858 jennifer.james[.]sas.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any SAS Institute, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Software via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From SAS Institute, Inc. / Company Profile


Read Software Most Recent Related Press Releases:

Kontron Introduces FabEagle®Connect - A Low-code Application for Interface Integration
Adept Builds a Powerful AI Teammate for Everyone with Oracle and NVIDIA
Siemens Selected by Microsoft for Rapid Assured Microelectronics Prototypes (RAMP) Program
Yardi Named Again to the Prestigious 2022 Forbes Cloud 100 List
Tovala Selects NetSuite to Heat Up the Meal Subscription Service Market
Amwell Applauded by Frost & Sullivan for its Comprehensive Digital Care Delivery Enablement Platform, Converge™
CentralSquare, NextNav Partner to Bring Z-axis Vertical Location to Public Safety Agencies Nationwide
OpenText Unveils Cloud Editions 22.3
Technology Solutions to Boost Employee Experience and Improve Patient Outcomes Says Frost & Sullivan
InfStones and Oracle Collaborate to Accelerate Web3 Development

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Limelon Advertising, Co.







 
  ©2022 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today